Press Release |
28 May 2010 |
("SI" or "the Group")
Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative medical devices, is pleased to announce a five year worldwide contract with Teleflex Medical ("Teleflex"), the designer, manufacturer and distributor of medical devices for critical care and surgical applications. The substantial contract is for the production of articulating handles with bespoke laparoscopic instrumentation.
Building upon a previous relationship, Teleflex approached SI to develop new handle technology. The articulating reusable handles have been under development by Teleflex and SI for two years and the unique, flexible nature improves the ergonomics and ease of use for surgeons performing keyhole surgery. SI retains the full intellectual property rights for the devices, subject to the rights of Teleflex to utilise the IP in the sale of the devices pursuant to the Supply Agreement. The initial roll out of the technology will be throughout Europe with the potential for expansion into the US.
Commenting on the agreement, Graham Bowland, Chief Executive Officer of SI, said: "This order represents an important milestone for our OEM business. We have been working successfully with Teleflex for more than 10 years and we are delighted to continue this successful relationship. Our in-house design, prototype and manufacturing facilities allow us to develop new and improved technologies which can be used by Teleflex to provide their surgeons with an innovative, cost effective laparoscopic device. We look forward to continuing our collaboration with Teleflex as we strive to develop new technologies to help surgeons perform less invasive surgeries."
- Ends -
For further information:
Surgical Innovations Group plc |
|
Doug Liversidge, Non-Executive Chairman |
Tel: +44 (0) 113 230 7597 |
Graham Bowland, Chief Executive Officer |
Tel: +44 (0) 113 230 7597 |
|
Westhouse Securities Limited |
|
Tim Feather / Matthew Johnson |
Tel: +44 (0) 113 246 2610 |
Media enquiries:
Abchurch Communications |
|
Sarah Hollins / Simone Elviss / Quincy Allan |
Tel: +44 (0) 20 7398 7728 |
Notes to Editors:
About Surgical Innovations Group plc
Surgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery and industrial markets. The Group has two divisions; Surgical Innovations Limited and Haemocell Limited.
The Group employs over 100 people at its 32,000 square feet facility in Leeds, with in-house design and the manufacturing of products to the highest quality standards. Through an established network of 45 distribution partners, SI sells in all major medical markets including North America, Europe, South Africa, the Middle East, South-East Asia and Australia.
Surgical Innovations Limited, the main trading subsidiary of the Group, is focused on developing medical instruments for the laparoscopic surgery market - minimally invasive surgery of the abdomen. The Group has pioneered Resposable® instrumentation combining both single use and reusable components ensuring an ongoing revenue stream and delivering the optimum procedure performance to cost ratio. The Group's products include:
YelloPort+plus® |
A resposable® laparoscopic port access system that combines both single-use and reusable components |
Logi®Range |
resposable® laparoscopic instrumentation that combines both single-use and reusable components |
Quick®Range |
single-use instruments, with an ergonomic handle to ensure accurate control of the instrument. The range includes scissors, graspers and dissectors |
In addition to its own branded instruments, the Group also designs and manufactures devices on an OEM basis for large medical device companies including Teleflex Medical, Gyrus, Olympus and Cardinal Health.
For more information, see www.surginno.com